Insights
Search Results
News Articles
3.16.26
Lawdragon Names Erin Fay Among 2026 “500 Leading Global Bankruptcy & Restructuring Lawyers”
On March 13, 2026, Lawdragon recognized Wilson Sonsini’s Erin Fay among its “500 Leading Global Bankruptcy & Restructuring Lawyers” for 2026. For this guide, Lawdragon conducted independent research, accepted nominations, and consulted with industry peers.
Client Highlights
12.15.25
Wilson Sonsini Advises Quantum Computing on $110 Million Acquisition of Luminar Semiconductor
On December 15, 2025, Quantum Computing (QCi), an innovative, quantum optics and integrated photonics technology company, announced that it has signed an agreement to acquire Luminar Semiconductor (LSI), a wholly owned subsidiary of Luminar Technologies, in an all-cash transaction valued at $110 million, subject to customary adjustments. Wilson Sonsini Goodrich & Rosati is advising QCi on the transaction
Client Highlights
10.17.25
Wilson Sonsini Advises Omeros on Asset Purchase and License Agreement with Novo Nordisk
On October 15, 2025, Novo Nordisk and Omeros Corporation announced that they have entered into a definitive asset purchase and license agreement for the candidate drug zaltenibart (OMS906) in clinical development for rare blood and kidney disorders. Wilson Sonsini Goodrich & Rosati advised Omeros on the transaction.
Client Highlights
8.28.25
Firm Advises SparkMeter on Platform Acquisition by Honeywell
On August 20, 2025, Honeywell announced the expansion of its Smart Energy portfolio with the tuck-in acquisition of three utility platforms from SparkMeter, Inc., a provider of leading grid management solutions for utilities. The acquisition includes intellectual property and certain related assets from SparkMeter. Wilson Sonsini Goodrich & Rosati advised SparkMeter on the transaction.
Client Highlights
7.25.25
Wilson Sonsini Advises Revival on Strategic Partnership with Olympus
On July 25, 2025, Revival Healthcare Capital (Revival), an investment firm focused on transformative external innovation partnerships in MedTech, announced a strategic partnership with Olympus Corporation (Olympus), a global healthcare leader committed to making people’s lives healthier, safer, and more fulfilling through advanced medical technologies and solutions. The partnership is aimed at harnessing external innovation to accelerate development and market entry for an endoluminal robotics platform initially targeting gastrointestinal (GI) treatments. Wilson Sonsini Goodrich & Rosati advised Revival on the transaction and on fund matters related to the transaction.
News Articles
6.30.25
Erin Fay Named to 2025 Lawdragon “500 Leading Global Bankruptcy & Restructuring Lawyers” List
On June 27, 2025, Lawdragon recognized Wilson Sonsini’s Erin Fay among its “500 Leading Global Bankruptcy & Restructuring Lawyers” for 2025. For this guide, Lawdragon conducted independent research, accepted nominations, and consulted with industry peers. Among those honored in the list are traditional bankruptcy lawyers, specialists in leveraged finance and restructuring, and litigators well-versed in financial litigation and distress.
News Articles
6.05.25
2025 Chambers USA Guide Recognizes Wilson Sonsini Practices, Attorneys
The 2025 Chambers USA guide has recognized Wilson Sonsini Goodrich & Rosati as a leading law firm in 39 geography-specific practice categories and named 86 Wilson Sonsini attorneys among the best in their fields. This year, the firm received three new practice area rankings, including in the Artificial Intelligence category, and four improved practice area rankings.
Client Highlights
2.20.25
Wilson Sonsini Advises Versant Ventures and OrbiMed on Helicore Biopharma's $65 Million Series A
On January 28, 2025, Helicore Biopharma, a biopharmaceutical company focused on the discovery and development of first-in-class glucose-dependent insulinotropic peptide (GIP) antagonists for obesity and related conditions, emerged from stealth with $65 million in Series A financing. The round was co-led by founding investor Versant Ventures and by OrbiMed, with participation from Longitude Capital and Wellington Management. Wilson Sonsini Goodrich & Rosati advised Versant Ventures and OrbiMed on the transaction.
News Articles
6.20.24
Erin Fay Honored Among 2024 Lawdragon "500 Leading Global Bankruptcy & Restructuring Lawyers"
On June 14, 2024, Lawdragon named Wilson Sonsini partner Erin Fay to its annual list of “500 Leading Global Bankruptcy & Restructuring Lawyers.” The list recognizes lawyers who help companies, their financiers, suppliers, and the universe of everyone impacted when companies go bust, need to transition, or work through difficulties. For this guide, Lawdragon conducted independent research and consulted with leaders in the area including traditional bankruptcy lawyers, specialists in leveraged finance and restructuring and litigators well-versed in financial litigation and distress.
News Articles
6.06.24
Wilson Sonsini Practices, Attorneys Named in 2024 Chambers USA Guide
Wilson Sonsini Goodrich & Rosati practices and attorneys were honored in the recently published 2024 edition of Chambers USA: America's Leading Lawyers for Business. This year, the firm was ranked in 36 geography-specific practice categories, while 79 attorneys were honored among the best in their fields.
Client Highlights
3.07.24
Wilson Sonsini Advises C4T on Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Germany
On March 4, 2024, C4 Therapeutics (C4T), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, announced that it has entered into a license and collaboration agreement with Merck KGaA, Darmstadt, Germany, which operates its healthcare business as EMD Serono in the U.S. and Canada, to exclusively discover two targeted protein degraders from C4T's internal discovery pipeline. Wilson Sonsini Goodrich & Rosati advised C4T on the transaction.
News Articles
6.01.23
2023 Chambers USA Guide Recognizes Wilson Sonsini Practices and Attorneys
The recently published 2023 edition of Chambers USA: America's Leading Lawyers for Business recognized numerous Wilson Sonsini Goodrich & Rosati practices and attorneys. This year, the firm was ranked in 35 geography-specific practice categories, while 79 attorneys were honored among the best in their fields.